[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Medical Care Ag ADR (FMS)

Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,821,270
  • Shares Outstanding, K 537,129
  • Annual Sales, $ 22,207 M
  • Annual Income, $ 1,107 M
  • EBIT $ 2,112 M
  • EBITDA $ 3,809 M
  • 60-Month Beta 0.77
  • Price/Sales 0.59
  • Price/Cash Flow 4.37
  • Price/Book 0.83

Options Overview Details

View History
  • Implied Volatility 64.34% (+2.52%)
  • Historical Volatility 25.61%
  • IV Percentile 36%
  • IV Rank 28.71%
  • IV High 163.32% on 02/11/26
  • IV Low 24.48% on 05/21/26
  • Expected Move (DTE 9) 1.74 (7.36%)
  • Put/Call Vol Ratio 4.00
  • Today's Volume 5
  • Volume Avg (30-Day) 30
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 1,252
  • Open Int (30-Day) 1,851
  • Expected Range 21.92 to 25.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.64
  • Growth Rate Est. (year over year) +155,993.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.44 +0.94%
on 08/05/26
26.42 -10.45%
on 08/03/26
-0.36 (-1.50%)
since 07/10/26
3-Month
20.55 +15.13%
on 06/02/26
26.42 -10.45%
on 08/03/26
+1.42 (+6.38%)
since 05/12/26
52-Week
20.02 +18.18%
on 05/05/26
27.64 -14.40%
on 10/09/25
-0.54 (-2.23%)
since 08/12/25

Most Recent Stories

More News
Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda

BAD HOMBURG, Germany , Aug. 3, 2026 /PRNewswire/ -- "Fresenius Medical Care delivered another quarter of highly profitable growth, driven by solid organic revenue growth and improved profitability,"...

FMS : 23.67 (-0.84%)
Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery

BAD HOMBURG, Germany, Aug. 3, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease, has...

FMS : 23.67 (-0.84%)
Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients

BAD HOMBURG, Germany , July 29, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with kidney diseases, today announced BEACON-US...

FMS : 23.67 (-0.84%)
Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy

BAD HOMBURG, Germany , July 20, 2026 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the introduction...

FMS : 23.67 (-0.84%)
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

BAD HOMBURG, Germany , June 3, 2026 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the global launch...

FMS : 23.67 (-0.84%)
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

BAD HOMBURG, Germany , May 28, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the launch...

FMS : 23.67 (-0.84%)
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

BAD HOMBURG, Germany , May 27, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with kidney diseases, presents new research...

FMS : 23.67 (-0.84%)
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

BAD HOMBURG, Germany , May 26, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, intends to execute a new...

FMS : 23.67 (-0.84%)
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

BAD HOMBURG, Germany , May 21, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has completed a milestone...

FMS : 23.67 (-0.84%)
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

BAD HOMBURG, Germany , May 20, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease,...

FMS : 23.67 (-0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable...

See More

Key Turning Points

3rd Resistance Point 25.02
2nd Resistance Point 24.78
1st Resistance Point 24.33
Last Price 23.67
1st Support Level 23.63
2nd Support Level 23.39
3rd Support Level 22.93

See More

52-Week High 27.64
Fibonacci 61.8% 24.73
Fibonacci 50% 23.83
Last Price 23.67
Fibonacci 38.2% 22.93
52-Week Low 20.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.